Study details
Enrolling now
Whole Body DWI vs. FDG PET
University of California, San Francisco
NCT IDNCT06630845ClinicalTrials.gov data as of Apr 2026
Target enrollment
30
Study length
about 4.7 years
Ages
18+
Locations
1 site in CA
About this study
Researchers are testing whether whole body diffusion weight imaging (DWI) is a better way to detect cancer than 18F-fludeoxyglucose (FDG) PET/MRI in people with metastatic cancer. The trial will last for about 1728 days and involve approximately 30 participants.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Fluorodeoxyglucose F18
- 2.Undergo Positron Emission Tomography combined with Magnetic resonance imaging (PET/MRI)
- 3.Undergo Whole Body Magnetic Resonance Imaging with Diffusion-Weighted Imaging (WB-MRI-DWI)
- +1 more
DrugFluorodeoxyglucose F18
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low4%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
fludeoxyglucose (18F)
Endpoints
Secondary: Inter-reader variability of diffusion weight imaging (DWI) interpretation
Procedures
imaging